Nearly 17 million people have been disenrolled from Medicaid since April 2023.
The Latest
Medicare Advantage enrollees received less intensive postacute care than their counterparts in traditional Medicare, but did not have a significant change in short-term outcomes, a study published Feb. 16 in JAMA Health Forum found.
From canceled acquisitions to contract challenges in court, these are five key updates about Blue Cross Blue Shield companies reported by Becker's in 2024:
Technology modernization and the alignment of investments with organizational goals, along with picking the right vendor to partner with, are top of mind for payer executives in 2024, according to a Jan. 30 survey published by digital solutions firm HealthEdge.
With fewer employees spending five days a week in-office, two of the nation's largest insurers are consolidating their headquarters.
From the Elevance-Blue Cross Blue Shield of Louisiana deal put on hold again to Cigna reaching a deal to sell its Medicare business, here are nine payer mergers and acquisitions updates Becker's has reported since Jan. 29:
UnitedHealthcare has named Michael Baker as chief operating officer.
Nebraska lawmakers are considering requiring the state's Medicaid program to cover GLP-1 drugs, the Omaha World-Herald reported Feb. 15.
Brian Pieninck has led CareFirst BlueCross BlueShield as president and CEO for nearly six years, and he was recently elected as chair of the Blue Cross and Blue Shield Association's board of directors.
It has been a busy few weeks for Medicare Advantage policy. CMS proposed a slight cut in benchmark rates, and payer executives were split on the impact of rising costs in the business.